CD47 mAb treatment combined with chemotherapy increased the number of macrophages and further enhanced their phagocytic capabilities in osteosarcoma, thus produced a better outcome in the osteosarcoma-bearing mice model (103). Here, CD47 is linked to osteosarcoma.